PRPO earnings date and last-quarter result: last quarter miss, P/E -48.80. Updated 2026-07-23.
Precipio (PRPO) Research Hub
Precipio (PRPO) trades on NASDAQ, US in the Healthcare (Medical - Diagnostics & Research) sector. As of 2026-10-26, shares last closed at 19.35 USD (-3.30%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -48.80, market cap 0.04B. This hub links to the full technical, earnings and options research available for PRPO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Diagnostics & Research) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 19.35 USD (-3.30%) |
| 52-week range | 19.1 USD – 32.57 USD |
| Trend regime | Range |
| 14-day RSI | 15 (Oversold) |
| Trailing P/E | -48.80 |
| Market cap | 0.04B |
| Dividend yield | 0.00% |
Available research for PRPO
Covered Call on PRPO: how it works, illustrative setup around the real 19.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on PRPO: how it works, illustrative setup around the real 19.35 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on PRPO: how it works, illustrative setup around the real 19.35 USD price, max profit/loss, breakeven and when to use it. Educational.
PRPO technical analysis: range, last 19.35 USD, RSI 15, 52w range 19.1 USD–32.57 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is PRPO in?
Precipio (PRPO) is classified under Healthcare (Medical - Diagnostics & Research), listed on NASDAQ, US.
Is PRPO in an uptrend or downtrend?
As of 2026-10-26, PRPO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is PRPO's trailing P/E ratio?
PRPO's trailing P/E is -48.80, with a market cap of 0.04B. See the earnings research page for full valuation detail.